Stay updated on Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record for the completed olaparib Phase 2 breast cancer study is displayed, including its eligibility criteria, treatment plan, outcome measures, participating locations, and results-related record dates.
    Difference
    58%
    Check dated 2026-11-09T13:44:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T15:45:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T15:45:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-19T21:44:39.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.1 instead of v3.7.0. The study record remains unavailable because the page displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:18:07.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details with an access-denied page. This makes the study information and locations inaccessible to users.
    Difference
    19%
    Check dated 2026-09-21T22:13:51.000Z thumbnail image

Stay in the know with updates to Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.